 ent and the work 
of the re muneration committee is found in note 5 of the Annual Report and in the Corporate 
Governance Report. 
 
Performance in 2024 
The CEO provides a summary of the company ’s overall performance in the CEO statement 
on page 6 of the Annual Repo rt. 
 
Overview of the implementation of the Remuneration Guidelines 
Sedana Medical’s long -term s uccess depends on the company being able to recruit and 
retain qualified personnel . According to the guidelines , remuneration to senior executives 
shall be on market terms and may consist of fixed cash salary, variable cash remuneration, 
pension and other benefits. Additionally, the annual general meeting may resolve on long-
term share -based incentive programs . The fixed remuneration shall reflect the individual’s 
responsibility and experience level. The v ariable remuneration shall be performance -based 
and linked to satisfaction of predetermined criteria measured over one year . The criteria for 
variable remun se. Detailed information about the performance target and the result 
of LTI 2024 will be provided during the first half of 2027. If the performance target is not 
reached, the participants’ right to utilize the performance rights will be gradually reduced to 
zero, depending on the extent to which the target has been achieved. At the end of the 
period, full utilization of LTI 2024 would increase the equity capital of the company by 37 
KSEK through the issue of 1,490,053 shares, which would correspond to dilution for 
shareholders of 1.5%. 
 
Table 2: Outstanding share -based incentive program CEO 
 
 
Table 3: Long-term share -based incentive program CEO (LTI 2024) 
 
 
 
Program name Date of awardPeriod for 
exercizeStrike 
priceInstruments 
(#)
2022/2025:1 11 may 202230 maj – 30 
september 202546,24 495 000 
LTI 2024 16 sep 2024 31 maj 2027 26,33 226 762 Johannes Doll (CEO)
Program 
nameDate of 
awardPeriod for 
exercizeStrike 
priceIntruments 
at start of 
the yearInstruments 
aw  yearInstruments 
awardedInstruments 
vestedInstruments 
vestedInstruments 
awarded, 
not vested
Johannes Doll (CEO) LTI 202416 sep 
202431 maj 
202726,33 - 226 762 - - 226 762 During the year Outgoing balance

Table 4: Comparative information related to changes in remuneration and the 
company’s fi nancial result (KSEK) 
 
Note 1: The current CEO Johannes Doll assumed the position in October 2021, which impacts the rate of change 
2021-2022. The ch ange of CEO also impacts the rate of change in remuneration for th e predecessor Christer 
Ahlberg during 2021. 
2020 vs 2019 2021 vs 2020 2022 vs 2021 2023 vs 2022 Year 2023 Year 2024
2212 2767 265 1 432 6676
na 125% 5% 27%
449 -582
21% -22%
-4 -40 -45 40 15 -51
-24% -190% -74% 38% 23%
224 -134 11 129 -72 1177
22% -11% 1% 11% -6%Remuneration to CEO 
(Johannes Doll)
Remuneration to CEO 
(Christer Ahlberg)
Group operating result 
(MSEK)
Average remuneration to 
employees (full-time 
equivalents)